Research has found that PRMT3 can enhance CKD‐induced vascular calcification by promoting the glycolysis process following the methylation of arginine in HIF‐1α, thereby facilitating the occurrence of vascular calcification. This evidence concerns the gene PRMT3 and chronic kidney disease.